Introduction

Background

CGMs have emerged as critical tools in diabetes management, enabling real-time tracking of glucose levels and improving patient outcomes. With the rise of digital health integration, AI- driven analytics, and expanding use cases beyond diabetes management, the CGM market is attracting heightened interest from medical device companies, tech firms, and investors. This report analyzes the current market landscape, competitive dynamics, and factors shaping the future of CGM.

Key Market Drivers and Trend

Technology
Technological advancements, including the integration of AI and machine learning to improve glucose trend predictions, device miniaturization, and the development of non-invasive CGM technologies, are driving innovation in the industry. These technologies are complemented by enhanced connectivity with smartphones and wearable devices, improving user experience and accessibility.

Regulatory
On the regulatory front, expanding insurance coverage for CGM devices under Medicare and private insurers, alongside FDA approvals for next- generation technologies, has lowered barriers to adoption. Additionally, the growing demand for value-based healthcare solutions has further solidified CGM’s role in patient management.

Market Adoption
Market adoption is also accelerating due to the rising prevalence of diabetes and prediabetes worldwide, increasing interest from non- diabetic users, including fitness enthusiasts, and the integration of CGM data into broader chronic disease management platforms.

Competitive Landscape

Research

Dexcom, Abbott, and Medtronic dominate the CGM market through continuous product innovation and global market penetration, while emerging players, including tech companies and new entrants, explore AI-powered and non-invasive solutions. Strategic collaborations between pharma, tech firms, and medical device manufacturers are driving innovation, with increased consolidation as established players acquire smaller firms. Pricing strategies are evolving with competition-driven adjustments, affordability initiatives, and subscription-based CGM models targeting direct-to-consumer markets.

Market Forecast & Growth Trends

The CGM market is expected to grow at a CAGR of approximately 12-15% between 2023 and 2027, driven by increased adoption, technological advancements, and expanded insurance coverage.

Strategic Consideration

Innovation and differentiation remain at the core of the CGM market’s evolution. Companies focus on continuous product innovation to enhance accuracy, affordability, and usability. Expanding into non-diabetic metabolic health markets broadens CGM applications beyond traditional use cases.

Regulatory compliance and market access strategies are pivotal, with firms navigating FDA approval pathways for next-generation devices and expanding global access through strategic partnerships and reimbursement negotiations.

Moreover, integrating data and digital health solutions is transforming the industry, as AI-driven glucose analytics offer personalized insights and digital health partnerships enhance telemedicine and remote patient monitoring capabilities.

Why You Need a Competitive Intelligence Partner for Success

In an industry defined by rapid technological advances, shifting regulations, and intensifying competition, staying ahead requires more than just innovation—it demands strategic foresight and informed decision-making.

Partnering with a competitive intelligence and strategy firm ensures your company can navigate these complexities. From intelligence monitoring, benchmarking competitors, conducting scenario workshops, and mitigating risks, firms provide actionable insights that enable companies to adapt, compete, and thrive in the CGM market.

Proactive Worldwide, a leading competitive intelligence and strategy firm, offers the expertise and tools your company needs to succeed. With deep industry knowledge and tailored solutions, PWW can help you anticipate market shifts, benchmark competitors, and craft winning strategies to achieve sustainable biotechnology/pharmaceutical market growth.